These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 25130184)

  • 1. Ethnic- and gender-specific differences in the prevalence of HIV among patients in opioid maintenance treatment-a case register analysis.
    Liebrenz M; Stohler R; Nordt C
    Harm Reduct J; 2014 Aug; 11():23. PubMed ID: 25130184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors associated with HIV/HCV infection among entrants in methadone maintenance treatment clinics in China: a systematic review and meta-analysis.
    Zhuang X; Wang Y; Chow EP; Liang Y; Wilson DP; Zhang L
    Drug Alcohol Depend; 2012 Dec; 126(3):286-95. PubMed ID: 22726912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of continued HIV-risk behaviors among drug users in methadone maintenance therapy program in China--a prospective study.
    Chen W; Xia Y; Hong Y; Hall BJ; Ling L
    Harm Reduct J; 2013 Oct; 10():23. PubMed ID: 24107380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buprenorphine/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: findings from starting treatment with agonist replacement therapies (START).
    Potter JS; Marino EN; Hillhouse MP; Nielsen S; Wiest K; Canamar CP; Martin JA; Ang A; Baker R; Saxon AJ; Ling W
    J Stud Alcohol Drugs; 2013 Jul; 74(4):605-13. PubMed ID: 23739025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in substance use in patients receiving opioid substitution therapy and resulting clinical challenges: a 17-year treatment case register analysis.
    Herdener M; Dürsteler KM; Seifritz E; Nordt C
    Lancet Psychiatry; 2017 Apr; 4(4):302-309. PubMed ID: 28258833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of buprenorphine and methadone among opioid users who inject drugs.
    Tsui JI; Burt R; Thiede H; Glick SN
    Subst Abus; 2018 Jan; 39(1):83-88. PubMed ID: 28796591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid addicted buprenorphine injectors: drug use during and after 12-weeks of buprenorphine-naloxone or methadone in the Republic of Georgia.
    Piralishvili G; Otiashvili D; Sikharulidze Z; Kamkamidze G; Poole S; Woody GE
    J Subst Abuse Treat; 2015 Mar; 50():32-7. PubMed ID: 25456093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender, cocaine and during-treatment HIV risk reduction among injection opioid users in methadone maintenance.
    Camacho LM; Bartholomew NG; Joe GW; Cloud MA; Simpson DD
    Drug Alcohol Depend; 1996 May; 41(1):1-7. PubMed ID: 8793304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One size does not fit all-evolution of opioid agonist treatments in a naturalistic setting over 23 years.
    Nordt C; Vogel M; Dey M; Moldovanyi A; Beck T; Berthel T; Walter M; Seifritz E; Dürsteler KM; Herdener M
    Addiction; 2019 Jan; 114(1):103-111. PubMed ID: 30209840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generating trust: Programmatic strategies to reach women who inject drugs with harm reduction services in Dar es Salaam, Tanzania.
    Zamudio-Haas S; Mahenge B; Saleem H; Mbwambo J; Lambdin BH
    Int J Drug Policy; 2016 Apr; 30():43-51. PubMed ID: 26880500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid treatment in Ukraine risks losing momentum.
    Bull World Health Organ; 2013 Feb; 91(2):87-8. PubMed ID: 23554519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methadone and buprenorphine-naloxone are effective in reducing illicit buprenorphine and other opioid use, and reducing HIV risk behavior--outcomes of a randomized trial.
    Otiashvili D; Piralishvili G; Sikharulidze Z; Kamkamidze G; Poole S; Woody GE
    Drug Alcohol Depend; 2013 Dec; 133(2):376-82. PubMed ID: 23916321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for kidney disease among HIV-1 positive persons in the methadone program.
    Matłosz B; Pietraszkiewicz E; Firląg-Burkacka E; Grycner E; Horban A; Kowalska JD
    Clin Exp Nephrol; 2019 Mar; 23(3):342-348. PubMed ID: 30218298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitigating the risk of HIV infection with opioid substitution treatment.
    Gowing LR; Hickman M; Degenhardt L
    Bull World Health Organ; 2013 Feb; 91(2):148-9. PubMed ID: 23554530
    [No Abstract]   [Full Text] [Related]  

  • 15. Maintenance agonist treatments for opiate-dependent pregnant women.
    Minozzi S; Amato L; Bellisario C; Ferri M; Davoli M
    Cochrane Database Syst Rev; 2013 Dec; (12):CD006318. PubMed ID: 24366859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unintended impacts of regulatory changes to British Columbia Methadone Maintenance Program on addiction and HIV-related outcomes: An interrupted time series analysis.
    Socías ME; Wood E; McNeil R; Kerr T; Dong H; Shoveller J; Montaner J; Milloy MJ
    Int J Drug Policy; 2017 Jul; 45():1-8. PubMed ID: 28454044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nevirapine induced opiate withdrawal among injection drug users with HIV infection receiving methadone.
    Altice FL; Friedland GH; Cooney EL
    AIDS; 1999 May; 13(8):957-62. PubMed ID: 10371177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV seroconversion and risk factors among drug users receiving methadone maintenance treatment in China: A qualitative study.
    Wang C; Shi CX; Zhang B; Chen H; Wang H; Zhang N; Rou K; Cao X; Luo W; Wu Z
    Drug Alcohol Depend; 2016 Oct; 167():169-74. PubMed ID: 27567967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV prevalence and gender differences among new injection-drug-users in Tallinn, Estonia: A persisting problem in a stable high prevalence epidemic.
    Uusküla A; Raag M; Marsh K; Talu A; Vorobjov S; Des Jarlais D
    PLoS One; 2017; 12(2):e0170956. PubMed ID: 28152026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment readiness, attitudes toward, and experiences with methadone and buprenorphine maintenance therapy among people who inject drugs in Malaysia.
    Vijay A; Bazazi AR; Yee I; Kamarulzaman A; Altice FL
    J Subst Abuse Treat; 2015 Jul; 54():29-36. PubMed ID: 25841703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.